NCT05795023View on ClinicalTrials.gov

A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

NACompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

October 28, 2024

Study Completion Date

October 28, 2024

Conditions

Parkinson Disease

Interventions

OTHER

NeuraLight

NeuraLight software-based platform

Trial Locations (1)

6423906

Movement Disorders Unit, Sourasky Tel Aviv Medical Center, Tel Aviv

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NeuraLight

INDUSTRY

NCT05795023 - A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients | Biotech Hunter | Biotech Hunter